Safety and Efficacy of Conivaptan in Hyponatremic Patients With Symptomatic Acute Decompensated Heart Failure (ADHF)

Stopped The clinical study has been terminated based on difficulties to enroll eligible subjects per protocol inclusion and exclusion criteria.

Conditions

• Hyponatremia
• Acute Decompensated Heart Failure

Interventions

• DRUG: conivaptan
• DRUG: placebo

Sponsor

Cumberland Pharmaceuticals